BlackRock’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-7,330,329
| Closed | -$82.1M | – | 5012 |
|
|
2017
Q3 | $82.1M | Buy |
7,330,329
+939
| +0% | +$10.5K | ﹤0.01% | 1947 |
|
|
2017
Q2 | $80.6M | Sell |
7,329,390
-245,334
| -3% | -$2.7M | ﹤0.01% | 1937 |
|
|
2017
Q1 | $74.2M | Buy |
7,574,724
+7,568,384
| +119,375% | +$74.2M | ﹤0.01% | 1966 |
|
|
2016
Q4 | $68K | Sell |
6,340
-1,223
| -16% | -$13.1K | ﹤0.01% | 2731 |
|
|
2016
Q3 | $78K | Buy |
7,563
+643
| +9% | +$6.63K | ﹤0.01% | 2686 |
|
|
2016
Q2 | $91K | Buy |
6,920
+2,586
| +60% | +$34K | ﹤0.01% | 2555 |
|
|
2016
Q1 | $48K | Buy |
4,334
+704
| +19% | +$7.8K | ﹤0.01% | 2334 |
|
|
2015
Q4 | $33K | Buy |
3,630
+1,800
| +98% | +$16.4K | ﹤0.01% | 2277 |
|
|
2015
Q3 | $13K | Hold |
1,830
| – | – | ﹤0.01% | 2599 |
|
|
2015
Q2 | $18K | Sell |
1,830
-400
| -18% | -$3.93K | ﹤0.01% | 2415 |
|
|
2015
Q1 | $20K | Hold |
2,230
| – | – | ﹤0.01% | 2343 |
|
|
2014
Q4 | $19K | Hold |
2,230
| – | – | ﹤0.01% | 2382 |
|
|
2014
Q3 | $16K | Hold |
2,230
| – | – | ﹤0.01% | 2426 |
|
|
2014
Q2 | $12K | Hold |
2,230
| – | – | ﹤0.01% | 2639 |
|
|
2014
Q1 | $10K | Hold |
2,230
| – | – | ﹤0.01% | 2722 |
|
|
2013
Q4 | $12K | Hold |
2,230
| – | – | ﹤0.01% | 2600 |
|
|
2013
Q3 | $12K | Hold |
2,230
| – | – | ﹤0.01% | 2537 |
|
|
2013
Q2 | $11K | Buy |
+2,230
| New | +$11K | ﹤0.01% | 2606 |
|